Quantabio Adds Powerful Bead Booster Chemistry to Ultra-Fast sparQ RNA...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: June 4, 2023

Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam • Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipili • TAGRISSO® achieved unprecedented survival in early-stage EGFR-mutated lung cancer, with 88% of patients alive at five years • High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy • Bijou Ikli named new CEO by Florida Assisted Living Association • Statement by the Prime Minister on Canadian Armed Forces Day • Puma Biotechnology Announces Presentation of Biomarker Findings from a Phase II Study of Alisertib with Paclitaxel versus Paclit • Cupshe Celebrates 8th Birthday with Exclusive Collection in Collaboration with Chanel Iman, Heather Rae El Moussa, and Brittany • Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y • GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting • Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different P • Government of Canada releases summary of actions taken to address the safety and wellbeing of Indigenous women, girls and 2SLGBT • Reigniting the Cancer Moonshot: Massive Bio Joins CancerX as Founding Member to Accelerate Innovation and AI Implementation in C • Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin • ELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Pl • Tips for a smooth transition to senior living from the San Luis Obispo assisted living professionals • Dorsett Wanchai Marks World Environment Day 2023 with Bold Paperless and Plastic-Free Sustainability Initiatives • New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing • Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023 • Nucleai and Mayo Clinic BioPharma Diagnostics Announce Strategic Collaboration to Transform Digital Pathology for Drug Developme

Quantabio Adds Powerful Bead Booster Chemistry to Ultra-Fast sparQ RNA-Seq HMR Kit

BEVERLY, Mass. , March 20 /Businesswire/ - Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced a new optimized Bead Booster chemistry for its sparQ RNA-Seq HMR Kit, an ultra-fast RNA next-generation sequencing (NGS) library preparation tool with ribosomal RNA (rRNA) and globin mRNA depletion. The kit features new optimizations that enable scientists to generate up to five times higher yields of high-quality stranded transcriptome libraries from human, mouse or rat (HMR) samples in 35% less total time with up to 30% cost savings compared to competitive technologies.

RNA-seq technologies can be challenging due to complicated workflows, read coverage biases, limited transcript diversity and high sample costs. The new Quantabio sparQ RNA-Seq HMR Kit with Bead Booster overcomes many of these issues by allowing scientists to produce sequencer-ready libraries with minimal hands-on time in only 4.5 hours, which is 30-minutes faster than the previous sparQ RNA-Seq HMR Kit workflow and 2.5-hours faster than standard technologies. With the Bead Booster chemistry, magnetic beads bind to the wall of the tube in a localized fashion and resuspend readily during the elution step. This enhances the user experience and simplifies the pipetting steps during the purification process. This automation-friendly optimization was designed to increase yields, improve consistency and minimize loss of material.

“The addition of the new Bead Booster chemistry is another example of our ongoing commitment to improving the overall user experience by accelerating workflows and enabling superior performance,” said Dave Schuster, Head of R&D, Quantabio. “Just like we have done for years with our gene expression tools for RT-qPCR, we will continue to apply our in-house expertise and core competencies to simplify complex NGS methods and make them more reproducible, robust and automation friendly. This includes a new sparQ mRNA-Seq Kit that is coming soon.”

The proprietary enzymes included in the sparQ RNA-Seq HMR Kit generate up to five times the yield of directional transcriptome libraries from 1 ng of high-quality, intact RNA and 10 ng of degraded FFPE RNA up to 1 µg of total HMR RNA input. This sample input versatility makes the kit ideal for a broad range of gene expression and transcriptome analysis cancer research applications, including translational studies, drug discovery, companion drug diagnostic testing, and mouse modeling. The sparQ RNA-Seq HMR Kit is available in 24 and 96-reaction configurations. For more information, please visit https://www.quantabio.com/product/sparq-rna-seq-hmr-kit/.

About Quantabio

Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. For the past 20 years, the Quantabio team has been developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical PCR, qPCR and Next-Generation Sequencing (NGS) based applications. Based in Beverly, Mass., Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers. For more information, please visit www.quantabio.com.

Quantabio products are intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.